Beta-glucuronidase and trypsin inhibitor capacity of tracheal lavage fluid as indicators of seasonal airway irritation in the horse.

The research monitors the health of horses’ respiratory tracts over almost a year, categorizing them into three groups according to the severity and frequency of their diseases. The levels of certain enzymes and biochemicals were measured, revealing that high levels of beta-glucuronidase serve as a reliable indicator of respiratory diseases in horses, found common in those with high neutrophil content, arterial alveolar, and intrapleural differences.

Methodology and Approach

• Over 11 months, the researchers studied the respiratory health of 19 horses and placed them into one of three groups. These placements were made based on measurements of a few indicators that included blood gases, intrapleural pressure, and the presence of neutrophils in the horses’ tracheal mucus.
• The groupings were ‘healthy’, ‘periodically diseased’, ‘continuously diseased’. The process was undertaken to determine whether there was a correlation between the progression and state of disease and the biochemical parameters being studied.

Findings and Observations

• A few lysosomal enzymes such as N-acetyl-beta-D-glucosaminidase and beta-glucuronidase were measured along with reflectors of the proteolytic system like plasmin, plasminogen, and trypsin inhibitor capacity
• The research showed that beta-glucuronidase can be a good indicator of respiratory diseases in horses. Horses that had elevated numbers of neutrophils or an increase in arterial alveolar and intrapleural differences also showed high beta-glucuronidase values.
• These high values were particularly prominent during the stabling period, when horses were confined, and among those that were classified as ‘diseased’. This observation suggests that stable conditions may contribute to respiratory diseases in horses.

Implications and Conclusions

• The study found a correlation between high beta-glucuronidase values and respiratory diseases in horses. It suggests that beta-glucuronidase could be used as a biomarker for monitoring the respiratory health of horses.
• Trypsin inhibitor capacity appeared to be lower in horses with diseased respiratory systems, likely due to increased consumption of trypsin inhibitors – a response to mitigating the progression of the disease.
• The evidence collected in this study permits veterinarians and horse owners to potentially predict and treat respiratory diseases through monitoring the biochemistry of infected horses more accurately.